Eculizumab Dosing Regimen in Atypical HUS: Possibilities for Individualized Treatment.
Volokhina E, Wijnsma K, van der Molen R, Roeleveld N, van der Velden T, Goertz J, Sweep F, Brüggemann RJ, Wetzels J, van de Kar N, van den Heuvel L.
Volokhina E, et al.
Clin Pharmacol Ther. 2017 Oct;102(4):671-678. doi: 10.1002/cpt.686. Epub 2017 May 26.
Clin Pharmacol Ther. 2017.
PMID: 28295239